Rockwell Medical, Inc. (DE) Common Stock (RMTI) Stock Price

RMTIStock

$7.95−30.70%52W

Market Cap$32.02M

P/E—

PEG Ratio4.43

Div yield—

Beta1.62

RMTI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-36.01%

Price vs S&P 500 (4W)9.97%

PEG Ratio4.43

VGM Score48.41

P/CF (Annual)8.97x

Book Value / Share (Quarterly)$9.08

P/TBV (Annual)1.20x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-1.65%

Cash Flow / Share (Quarterly)$0.45

Price vs S&P 500 (YTD)-17.23%

Gross Margin (TTM)18.10%

Net Profit Margin (TTM)-7.98%

EPS (TTM)$-1.08

10-Day Avg Trading Volume0.03M

EPS Excl Extra (TTM)$-1.08

Revenue Growth (5Y)2.17%

EPS (Annual)$-1.48

ROI (Annual)-11.34%

Gross Margin (Annual)18.62%

Net Profit Margin (5Y Avg)-19.33%

Cash / Share (Quarterly)$6.05

Revenue Growth QoQ (YoY)-8.34%

ROA (Last FY)-9.30%

Revenue Growth TTM (YoY)-30.75%

EBITD / Share (TTM)$-0.23

ROE (5Y Avg)-294.82%

Operating Margin (TTM)-7.11%

Cash Flow / Share (Annual)$-0.30

P/B Ratio0.84x

P/B Ratio (Quarterly)0.98x

Net Income / Employee (Annual)$-33,800

EV / Revenue (TTM)0.44x

Net Interest Coverage (TTM)-7.53x

ROA (TTM)-9.62%

EV / EBITDA (TTM)33.60x

EPS Incl Extra (Annual)$-1.48

Current Ratio (Annual)3.98x

Quick Ratio (Quarterly)3.32x

3-Month Avg Trading Volume0.03M

52-Week Price Return-30.70%

EV / Free Cash Flow (Annual)10.71x

Revenue / Employee (TTM)$431,100

Tangible BV / Share (Quarterly)$6.67

P/S Ratio (Annual)0.43x

Asset Turnover (Annual)1.21x

52-Week High$21.00

Operating Margin (5Y Avg)-17.24%

EPS Excl Extra (Annual)$-1.48

CapEx CAGR (5Y)-12.39%

Tangible BV CAGR (5Y)-3.65%

26-Week Price Return-24.76%

Quick Ratio (Annual)3.46x

13-Week Price Return-2.47%

Total Debt / Equity (Annual)0.27x

Current Ratio (Quarterly)3.74x

Enterprise Value$30.11M

Revenue / Share Growth (5Y)16.29%

Asset Turnover (TTM)1.20x

Book Value / Share Growth (5Y)18.51%

Revenue / Employee (Annual)$441,100

Inventory Turnover (Annual)12.25x

Pretax Margin (Annual)-7.67%

Cash / Share (Annual)$6.34

3-Month Return Std Dev61.04%

Gross Margin (5Y Avg)9.59%

Net Income / Employee (TTM)$-34,400

ROE (Last FY)-14.37%

Net Interest Coverage (Annual)-8.11x

EPS Basic Excl Extra (Annual)$-1.48

P/FCF (TTM)7.74x

Receivables Turnover (TTM)7.32x

EV / Free Cash Flow (TTM)17.14x

Total Debt / Equity (Quarterly)0.27x

EPS Incl Extra (TTM)$-1.08

Receivables Turnover (Annual)8.43x

ROI (TTM)-11.98%

P/S Ratio (TTM)0.44x

Pretax Margin (5Y Avg)-19.33%

Revenue / Share (Annual)$19.25

Tangible BV / Share (Annual)$6.93

Price vs S&P 500 (52W)-49.01%

Year-to-Date Return-5.28%

5-Day Price Return5.05%

EPS Normalized (Annual)$-1.48

ROA (5Y Avg)-26.72%

Net Profit Margin (Annual)-7.67%

Month-to-Date Return9.87%

Cash Flow / Share (TTM)$-0.70

EBITD / Share (Annual)$-0.69

Operating Margin (Annual)-6.77%

LT Debt / Equity (Annual)0.24x

P/CF (TTM)11.30x

ROI (5Y Avg)-51.24%

LT Debt / Equity (Quarterly)0.23x

EPS Basic Excl Extra (TTM)$-1.08

P/TBV (Quarterly)1.34x

P/B Ratio (Annual)0.89x

Inventory Turnover (TTM)13.69x

Pretax Margin (TTM)-7.98%

Book Value / Share (Annual)$9.38

Price vs S&P 500 (13W)-5.26%

Beta1.62x

P/FCF (Annual)9.43x

Revenue / Share (TTM)$17.17

ROE (TTM)-15.41%

52-Week Low$4.88

vGradeB

gGradeD

mGradeC

vgmGradeC

RMTI Earnings Surprise History

Q2 25-0.50est. -0.50

Q3 25-0.50est. -0.45

Q4 25-0.10est. 0.20

Q1 26-0.40est. -0.25

Q2 26-0.34est. -0.23

RMTI Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
RMTIRockwell Medical, Inc. (DE) Common Stock	B	D	C	$7.95
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Rockwell Medical, Inc. (DE) Common Stock

Rockwell Medical Inc manufactures and distributes dialysis concentrates—essential consumables used in hemodialysis treatment. The company supplies liquid and dry bicarbonate and acid formulations, including CitraPure, RenalPure, and SteriLyte, to dialysis providers across the United States. It operates in a stable, recurring-revenue market driven by the ongoing treatment needs of dialysis patients.